Biora Therapeutics Stock Buy Hold or Sell Recommendation
| BIOR Stock | USD 1.67 0.04 2.45% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Biora Therapeutics is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Biora Therapeutics given historical horizon and risk tolerance towards Biora Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Biora Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Biora Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Biora Stock, please use our How to Invest in Biora Therapeutics guide. Note, we conduct extensive research on individual companies such as Biora and provide practical buy, sell, or hold advice based on investors' constraints. Biora Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Biora |
Execute Biora Therapeutics Buy or Sell Advice
The Biora recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biora Therapeutics. Macroaxis does not own or have any residual interests in Biora Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biora Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Biora Therapeutics Trading Alerts and Improvement Suggestions
| Biora Therapeutics generated a negative expected return over the last 90 days | |
| Biora Therapeutics has high historical volatility and very poor performance | |
| Biora Therapeutics may become a speculative penny stock | |
| Biora Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4 K. Net Loss for the year was (124.11 M) with profit before overhead, payroll, taxes, and interest of 1.25 M. | |
| Biora Therapeutics currently holds about 37.06 M in cash with (48.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Biora Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Wainwright lifts Biora Therapeutics stock target, keeps Buy rating on Q3 report |
Biora Therapeutics Returns Distribution Density
The distribution of Biora Therapeutics' historical returns is an attempt to chart the uncertainty of Biora Therapeutics' future price movements. The chart of the probability distribution of Biora Therapeutics daily returns describes the distribution of returns around its average expected value. We use Biora Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biora Therapeutics returns is essential to provide solid investment advice for Biora Therapeutics.
| Mean Return | -1.84 | Value At Risk | -13.65 | Potential Upside | 7.09 | Standard Deviation | 6.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biora Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biora Stock Institutional Investors
The Biora Therapeutics' institutional investors refer to entities that pool money to purchase Biora Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Barclays Plc | 2024-06-30 | 5.8 K | Wells Fargo & Co | 2024-06-30 | 4.1 K | Efficient Wealth Management Llc | 2024-09-30 | 1.5 K | Td Waterhouse Canada Inc | 2024-06-30 | 1.1 K | Advisor Group Holdings, Inc. | 2024-06-30 | 647 | Riggs Asset Management Co Inc | 2024-06-30 | 400 | Bank Of America Corp | 2024-06-30 | 179 | Hartland & Co | 2024-06-30 | 144 | Royal Bank Of Canada | 2024-06-30 | 74.0 | Athyrium Capital Management Lp | 2024-06-30 | 10.9 M | Vanguard Group Inc | 2024-06-30 | 697.3 K |
Biora Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 20.3M | (4.9M) | (1.2M) | (792K) | (98K) | (93.1K) | |
| Change In Cash | (16.0M) | 59.0M | (3.7M) | (57.9M) | (15.3M) | (14.5M) | |
| Free Cash Flow | (109.8M) | (170.7M) | (168.3M) | (65.2M) | (48.6M) | (51.0M) | |
| Depreciation | 6.3M | 5.1M | 1.4M | 907K | 555K | 527.3K | |
| Other Non Cash Items | 535K | 3.7M | 1.6M | (30.3M) | 50.0M | 52.5M | |
| Capital Expenditures | 3.7M | 4.9M | 855K | 792K | 103K | 97.9K | |
| Net Income | (148.0M) | (192.5M) | (178.5M) | (38.2M) | (124.1M) | (130.3M) | |
| End Period Cash Flow | 33.0M | 92.1M | 88.4M | 30.5M | 15.2M | 14.5M |
Biora Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biora Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biora Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biora stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.05 | |
β | Beta against Dow Jones | 1.67 | |
σ | Overall volatility | 6.40 | |
Ir | Information ratio | -0.31 |
Biora Therapeutics Volatility Alert
Biora Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biora Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biora Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biora Therapeutics Fundamentals Vs Peers
Comparing Biora Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biora Therapeutics' direct or indirect competition across all of the common fundamentals between Biora Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biora Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biora Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biora Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biora Therapeutics to competition |
| Fundamentals | Biora Therapeutics | Peer Average |
| Return On Asset | -1.25 | -0.14 |
| Operating Margin | (49.64) % | (5.51) % |
| Current Valuation | 44 M | 16.62 B |
| Shares Outstanding | 4.52 M | 571.82 M |
| Shares Owned By Insiders | 0.10 % | 10.09 % |
| Shares Owned By Institutions | 29.39 % | 39.21 % |
| Number Of Shares Shorted | 201.8 K | 4.71 M |
| Price To Sales | 8.78 X | 11.42 X |
| Revenue | 4 K | 9.43 B |
| Gross Profit | 1.25 M | 27.38 B |
| EBITDA | (114.05 M) | 3.9 B |
| Net Income | (124.11 M) | 570.98 M |
| Cash And Equivalents | 37.06 M | 2.7 B |
| Cash Per Share | 0.19 X | 5.01 X |
| Total Debt | 47.43 M | 5.32 B |
| Current Ratio | 1.69 X | 2.16 X |
| Book Value Per Share | (36.43) X | 1.93 K |
| Cash Flow From Operations | (48.5 M) | 971.22 M |
| Short Ratio | 2.94 X | 4.00 X |
| Earnings Per Share | 0.36 X | 3.12 X |
| Target Price | 34.0 | |
| Number Of Employees | 58 | 18.84 K |
| Beta | 1.28 | -0.15 |
| Market Capitalization | 7.55 M | 19.03 B |
| Total Asset | 31.21 M | 29.47 B |
| Retained Earnings | (950.96 M) | 9.33 B |
| Working Capital | (43.9 M) | 1.48 B |
| Current Asset | 667 K | 9.34 B |
| Current Liabilities | 3.01 M | 7.9 B |
| Net Asset | 31.21 M |
Note: Disposition of 117881 shares by Mohanty Aditya P. of Biora Therapeutics at 3.14 subject to Rule 16b-3 [view details]
Biora Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biora . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biora Therapeutics Buy or Sell Advice
When is the right time to buy or sell Biora Therapeutics? Buying financial instruments such as Biora Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biora Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Measuring and Control Equipment Thematic Idea Now
Measuring and Control Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Measuring and Control Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Measuring and Control Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.